Hematologic malignancies following immune checkpoint inhibition for solid tumors

Immune checkpoint inhibition (ICI) can induce durable responses in patients with advanced malignancies. Three cases of hematological neoplasia following ICI for solid tumors have been reported to date. We present five patients treated at our tertiary referral center between 2017 and 2021 who develop...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eijs, Mick J. M., van der Wagen, Lotte E., Mous, Rogier, Leguit, Roos J., van de Corput, Lisette, van Lindert, Anne S. R., Suelmann, Britt B. M., Kamphuis, Anna M., Nierkens, Stefan, Suijkerbuijk, Karijn P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188911/
https://www.ncbi.nlm.nih.gov/pubmed/35691988
http://dx.doi.org/10.1007/s00262-022-03230-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188911/
https://www.ncbi.nlm.nih.gov/pubmed/35691988
http://dx.doi.org/10.1007/s00262-022-03230-4

Ejemplares similares